INCR (Intercure) EV-to-FCF: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INCR Intercure Ltd INCR
67 GF Score
Price $0.99
GF Value $1.27
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Intercure EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Intercure's Enterprise Value is $102.21 Mil. Intercure's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil. Therefore, Intercure's EV-to-FCF for today is .

The historical rank and industry rank for Intercure's EV-to-FCF or its related term are showing as below:

INCR' s EV-to-FCF Range Over the Past 10 Years
Min: -54.35   Med: -4.92   Max: 61.53
Current: 23.17

During the past 13 years, the highest EV-to-FCF of Intercure was 61.53. The lowest was -54.35. And the median was -4.92.

INCR's EV-to-FCF is ranked worse than
51.96% of 562 companies
in the Drug Manufacturers industry
Industry Median: 21.055 vs INCR: 23.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-14), Intercure's stock price is $0.99. Intercure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.219. Therefore, Intercure's PE Ratio (TTM) for today is At Loss.


Intercure  (NAS:INCR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Intercure's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.99/-0.219
=At Loss

Intercure's share price for today is $0.99.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Intercure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.219.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Intercure EV-to-FCF Related Terms


Intercure EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Intercure's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intercure EV-to-FCF Chart

Intercure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.80 15.78 -4.87 -5.05 21.57

Intercure Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.87 0.00 -5.05 0.00 21.57

INCR vs CTOR, TLPH, ETST: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Intercure's EV-to-FCF falls into.


INCR
67GF Score
Intercure Ltd INCR
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intercure EV-to-FCF Calculation

Intercure's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=102.213/0
=

Intercure's current Enterprise Value is $102.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Intercure's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Intercure (INCR) Overvalued in 2026?

Based on GuruFocus' analysis, Intercure stock appears to be undervalued. The current stock price of $0.99 is trading 22% below its estimated GF Value™ of $1.27. GuruFocus considers Intercure to be Modestly Undervalued.

Key valuation signals for INCR:

  • EV-to-FCF:
  • GF Value™: $1.27 vs. price of $0.99 (22% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the INCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Intercure Business Description

Other Exchanges INCR:Israel
Address 85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
67GF Score

Get the complete analysis for INCR

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price
$1.27
GF Value